← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksASRTRevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

ASRT logoAssertio Holdings, Inc. (ASRT) Revenue History

Annual and quarterly revenue from 2014 to 2025

TTM Revenue
$118.7M
vs. $125.0M LY
YoY Growth
-57.9%
Declining
Latest Quarter
$13.5M
Q4 2025
QoQ Growth
-72.6%
Declining

Compound Annual Growth Rate (CAGR)

3-Year-8.7%Declining
5-Year+1.9%Slow
10-Year-10.1%Declining
Highest Annual Revenue$455.9M (2016)
Highest Quarter$128.4M (Q1 2018)
Revenue per Share$18.54
Revenue per Employee$2.0M

Loading revenue history...

ASRT Revenue Growth

1-Year Growth
-57.9%
Declining
3-Year CAGR
-8.7%
Declining
5-Year CAGR
+1.9%
Slow
10-Year CAGR
-10.1%
Declining
TTM vs Prior Year$6.3M (-5.0%)
Revenue per Share$18.54
Revenue per Employee$2.0M
Peak Annual Revenue$455.9M (2016)

Revenue Breakdown (FY 2025)

ASRT's revenue distribution by segment and geography for fiscal year 2025

By Product/Segment

Product74.9%
INDOCIN Products12.1%
Product, Other6.8%
SPRIX Nasal Spray5.1%
Royalty1.0%

By Geography

CANADA100.0%

Download Historical Data

12 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

ASRT Revenue Analysis (2014–2025)

As of May 8, 2026, Assertio Holdings, Inc. (ASRT) generated trailing twelve-month (TTM) revenue of $118.7 million, reflecting significant decline in growth of -57.9% year-over-year. The most recent quarter (Q4 2025) recorded $13.5 million in revenue, down 72.6% sequentially.

Looking at the longer-term picture, ASRT's 5-year compound annual growth rate (CAGR) stands at +1.9%, indicating moderate growth over time. The company achieved its highest annual revenue of $455.9 million in 2016.

Revenue diversification analysis shows ASRT's business is primarily driven by Product (75%), INDOCIN Products (12%), and Product, Other (7%). With over half of revenue concentrated in Product, the company maintains significant focus in this area while developing other growth vectors.

When compared to Healthcare sector peers including PAHC (+32.4% YoY), AMRX (+8.0% YoY), and SUPN (+16.3% YoY), ASRT has underperformed the peer group in terms of revenue growth. Compare ASRT vs PAHC →

ASRT Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
ASRT logoASRTCurrent$119M-57.9%+1.9%-18.1%
PAHC logoPAHC$1.3B+32.4%+10.1%8.5%
AMRX logoAMRX$3.0B+8.0%+8.7%-0.2%
SUPN logoSUPN$719M+16.3%+6.7%-5.1%
PRGO logoPRGO$4.3B-3.6%+0.8%8.1%
COLL logoCOLL$781M+19.9%+20.3%24.0%
Best in groupLowest in group

ASRT Historical Revenue Data (2014–2025)

Showing 10 of 12 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$118.7M-5.0%$83.3M70.2%$-21,536,000-18.1%
2024$125.0M-17.8%$85.7M68.6%$-24,476,000-19.6%
2023$152.1M-2.7%$125.0M82.2%$-243,536,000-160.1%
2022$156.2M+40.7%$137.5M88.0%$39.4M25.2%
2021$111.0M+2.7%$95.2M85.7%$9.4M8.5%
2020$108.1M-52.9%$92.3M85.4%$-82,155,000-76.0%
2019$229.5M-26.4%$220.0M95.9%$-194,428,000-84.7%
2018$311.8M-18.1%$293.3M94.1%$43.7M14.0%
2017$380.7M-16.5%$308.1M80.9%$-42,180,000-11.1%
2016$455.9M+33.0%$368.5M80.8%$24.5M5.4%

See ASRT's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is ASRT Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare ASRT vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

ASRT — Frequently Asked Questions

Quick answers to the most common questions about buying ASRT stock.

Is ASRT's revenue growth accelerating or slowing?

ASRT revenue declined -57.9% year-over-year, contrasting with the 5-year CAGR of +1.9%. TTM revenue fell to $119M. This reverses the prior growth trend.

What is ASRT's long-term revenue growth rate?

Assertio Holdings, Inc.'s 5-year revenue CAGR of +1.9% reflects the variable expansion pattern. Current YoY growth of -57.9% is below this long-term average.

How is ASRT's revenue distributed by segment?

ASRT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

ASRT Revenue Over Time (2014–2025)